Principal Investigator:

Lay Description:

H3Africa provides an unprecedented opportunity to study genetic and genomic technologies into research, diagnosis, intervention, and treatment for sickle cell disease (SCD) in Africa. As such, involving a few African centres already at the forefront of SCD Research in Africa with moderate expertise on psychosocial research (Cameroon), newborn screening (Ghana) or genomics studies (Tanzania) could serve as a reservoir for rigorous examinations of a wide range of accompanying ethical, psychosocial, cultural, and policy is

Related projects